Drug Promising In Immune System Therapy

U.S. medical scientists say they've determined a drug used to treat multiple myeloma also shows promise in immune system therapy. Dana- Farber Cancer Institute researchers conducted the trial that was designed to determine if the drug bortezomib (Velcadea) could improve immune system recovery in patients receiving stem cell transplants from unrelated, partially matched donors.